Feasibility of implantable cardioverter defibrillator treatment in five patients with familial friedreich's ataxia-A case series

Artificial Organs

Volumn 34, Issue 11, 2010, Pages 1061-1065

  Coskun, Kasim Oguz ^a   Popov, Aron Frederik ^c   Schmitto, Jan Dieter ^d   Coskun, Sinan Tolga ^b   Brandes, Ivo ^a   Zenker, Dieter ^a   Melnychenko, Ivan ^a   Schoendube, Friedrich Albert ^a   Ruschewski, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmias; Cardiomyopathy; Friedreich's ataxia; Implantable cardioverter defibrillator

Indexed keywords

ARTIFICIAL HEART; DEFIBRILLATORS; DIAGNOSIS; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; IMPLANTS (SURGICAL); NEURODEGENERATIVE DISEASES; PATIENT TREATMENT;

CARDIOMYOPATHY; CAUSES OF DEATH; CENTRAL NERVOUS SYSTEMS; FRATAXIN; FRIEDREICH'S ATAXIAS; GENOTYPING; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; IMPLANTABLE CARDIOVERTERS-DEFIBRILLATORS; MEAN AGES; PEDIATRIC PATIENTS;

HEART;

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FRATAXIN;

ADOLESCENT; ANGIOCARDIOGRAPHY; ARTICLE; CASE STUDY; CHILD; CLINICAL ARTICLE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; FRIEDREICH ATAXIA; GENE LOCUS; GENOTYPE; HEART CATHETERIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LITERATURE; MALE; NEUROLOGIC EXAMINATION; NEUROMUSCULAR SYSTEM; PEDIATRICS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROVOCATION TEST; QRS COMPLEX; SCHOOL CHILD; SUDDEN DEATH; TENDON REFLEX;

ANGINA;

EID: 78649548397     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01140.x     Document Type: Article

References (34)

1. Pandolfo M. Friedrich ataxia. Arch Neurol 2008;65:1296-303.
2. Leonard H, Forsyth R. Friedrich's ataxia presenting after cardiac transplantation. Arch Dis Child 2001;84:167-8.
3. Fineschi V, Panarese F, Zeppa P, et al. Sudden cardiac death in a case of spinocerebellar ataxia (Friedrich-like phenotype). Int J Cardiol 2006;106:424-5.
4. Sohi GS, Drake C, Flowers NC. Friedrich's ataxia associated with hypertrophic cardiomyopathy and coronary vasospasm. Clin Cardiol 1985;8:537-41.
5. Giugliano GR, Sethi PS. Friedrich's ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 2007;34:214-7.
6. Yoda M, El-Banayosy A, Arusoglu L, et al. Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedrich's ataxia. J Heart Lung Transplant 2006;25:251-2.
7. Smith ER, Sangalang VE, Heffernan LP, et al. Hypertrophic cardiomyopathy: the heart disease of Friedrich's ataxia. Am Heart J 1977;94:428-34.
8. Harding A. Friedrich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981;104:598-620.
9. Gallagher CL, Waclawik AJ, Beinlich BR, et al. Friedrich's ataxia associated with mitochondrial myopathy: clinicopathologic report. J Child Neurol 2002;17:453.
10. Raman SV, Dickerson JA, Al-Dahhak R. Myocardial ischemia in the absence of epicardial coronary artery disease in Friedrich's ataxia. J Cardiovasc Magn Reson 2008;10:15.
11. Ferres-Sanchez P, Subirana-Domenech M, Torner-Soler M. Chest pain during exercise as first manifestation of Friedrich's ataxia. Br Heart J 1995;74:464-7.
12. Dürr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedrich ataxia. N Engl J Med 1996;335:1169-75.
13. Gach JV, Andriange M, Franck G. Hypertrophic obstructive cardiomyopathy and Friedrich's ataxia. Am J Cardiol 1971;27:436-41.
14. Albano LM, Nishioka SA, Moyses RL, et al. Friedrich's ataxia: cardiac evaluation of 25 patients with clinical diagnosis and literature review. Arq Bras Cardiol 2002;78:444-51.
15. Sharma AK, Kiyokawa M, Kim ET, Lee DT, Kasuya R. Acute myocardial infarction and Friedrich's ataxia. Hawaii Med J 2002;61:199-201.
16. Child JS, Perloff JK, Bach PM, et al. Cardiac involvement in Friedrich's ataxia: a clinical study of 75 patients. J Am Coll Cardiol 1986;7:1370-8.
17. James TN, Fisch C. Observations on the cardiovascular involvement in Friedrich's ataxia. Am Heart J 1963;66:164-70.
18. Schulz JB, Dehmer T, Schools L, et al. Oxidative stress in patients with Friedrich ataxia. Neurology 2000;55:1719-21.
19. Babcock M, De Silva D, Oaks R, et al. Regulation of mitochondrial iron accumulation by Yfh1 p, a putative homolog of frataxin. Science 1997;276:1709-12.
20. Kosutic J, Zamurovic D. High dose beta-blocker hypertrophic cardiomyopathy therapy in a patient with Friedrich ataxia. Ped Cardiol 2005;26:727-30.
21. Gauthier EJ. Cardiac disease in Friedrich's ataxia. Ann Intern Med 1964;60:892-7.
22. Dutka DP, Donnelly JE, Nihoyannopoulos P, et al. Marked variation in the cardiomyopathy associated with Friedrich's ataxia. Heart 1999;81:141-7.
23. Harding AE, Hewer RL. The heart disease of Friedrich's ataxia: a clinical and electrocardiographic study of 115 patients with an analysis of serial electrocardiographic changes in 30 cases. Q J Med 1983;52:489-502.
24. James TN, Cobbs BW, Coghlan HC, Mccoy WC, Fisch C. Coronary disease, cardioneuropathy and conduction system abnormalities in the cardiomyopathy of Friedrich's ataxia. Br Heart J 1987;57:446-57.
25. Casazza F, Morpurgo M. The varying evaluation of Friedrich's ataxia cardiomyopathy. Am J Cardiol 1996;77:895-8.
26. Perloff JK, Stevenson WG, Roberts NK, et al. Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol 1984;54:1074-81.
27. James TN. Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. Am Heart J 1962;63:48-56.
28. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-484.
29. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117:350-408.
30. Epstein AE, Dimarco JP, Ellenbogen KA, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008;5:1-62.
31. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004;27:924-32.
32. Costa R, Da Silva KR, Mendonça RC, et al. Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator. Arq Bras Cardiol 2007;88:258-64.
33. Mark DB, Anstrom KJ, Sun JL, et al. Quality of life with defibrilator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008.
34. Bourke JP. Cardiac monitoring and treatement for children and adolescents with neuromuscular disorders. Develop Med Child. Neurology 2006;48:164.